DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENTDevelopment, Supply and Commercialization Agreement • September 25th, 2018 • Eton Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT (this “Agreement”) dated as of November 7, 2017 (the “Effective Date”), is entered into between ***, with a place of business at ***, and ETON PHARMACEUTICALS, INC., a Delaware corporation (“Eton”), with a place of business at 21925 Field Pkwy, Suite 235, Deer Park, Illinois 60010. The parties hereby agree as follows:
DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENTDevelopment, Supply and Commercialization Agreement • October 18th, 2018 • Eton Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENT (this “Agreement”) dated as of November 7, 2017 (the “Effective Date”), is entered into between AMPHASTAR PHARMACEUTICALS, INC., a Delaware corporation, (“Amphastar”), with a place of business at 11570 6th Street, Rancho Cucamonga, California 91730, and ETON PHARMACEUTICALS, INC., a Delaware corporation (“Eton”), with a place of business at 21925 Field Pkwy, Suite 235, Deer Park, Illinois 60010. The parties hereby agree as follows:
DEVELOPMENT, SUPPLY AND COMMERCIALIZATION AGREEMENTDevelopment, Supply and Commercialization Agreement • May 19th, 2020 • BIO-TECHNE Corp • Biological products, (no disgnostic substances) • New York
This Development, Supply and Commercialization Agreement (this “Agreement”), effective as of May 19, 2020 (the “Effective Date”), is by and between Kantaro Biosciences LLC, a Delaware limited liability company with a principal business address of 1460 Broadway, New York, NY 10036 (“Sponsor”) and Bio-Techne Corporation, a Minnesota corporation having a principal business address at 614 McKinley Place NE, Minneapolis, MN 55413 (“Bio-Techne”). Capitalized terms used and not defined elsewhere in this Agreement have the meanings set forth in Section 1 of this Agreement.
